Cannatrek shareholders overwhelmingly approve Little Green Pharma merger

Medicinal cannabis company Cannatrek has secured overwhelming shareholder approval for its merger with Little Green Pharma (ASX: LGP), paving the way for the creation of one of the largest vertically integrated medicinal cannabis businesses globally with pro-forma revenue of about $112…


Click here to view the original article.